NCT05456269 - A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS[/BCOLOR]
NCT04989335 -
Brief Title: Bisantrene Combination for Resistant AML
Official Title: An Open-label, Phase II, Two-stage, Study of Bisantrene(Xantrene) in Combination With Fludarabine and Clofarabine as Salvage Therapy for Adult Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
NCT05456269 - A Study of Bisantrene Combined With Cytarabine or...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
0.020(1.64%) |
Mkt cap ! $203.6M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.27 | $1.19 | $111.8K | 90.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2078 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.27 | 9029 | 1 |
View Market Depth
| Last trade - 15.48pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.23 |
Change
0.020 ( 2.94 %) |
||||
| Open | High | Low | Volume | ||
| $1.22 | $1.27 | $1.20 | 20698 | ||
| Last updated 15.58pm 08/05/2024 ? | |||||
| RAC (ASX) Chart |